Verteporfin In Photodynamic Therapy (VIP)

May 1, 2001

Clinical trial

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization–verteporfin in photodynamic therapy report 2.

Am J Ophthalmol. 2001 May;131(5):541-60.
Full text | Metrics.

Share This Article :

Updated on March 7th, 2022

Source Archive